| 000 | 01566 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250516092512.0 | ||
| 264 | 0 | _c20130115 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a2159-8290 | ||
| 024 | 7 |
_a10.1158/2159-8290.CD-11-0242 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFrese, Kristopher K | |
| 245 | 0 | 0 |
_anab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer. _h[electronic resource] |
| 260 |
_bCancer discovery _cMar 2012 |
||
| 300 |
_a260-269 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlbumins _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 |
_aCarcinoma, Pancreatic Ductal _xdrug therapy |
| 650 | 0 | 4 |
_aCytidine Deaminase _xmetabolism |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aNeesse, Albrecht | |
| 700 | 1 | _aCook, Natalie | |
| 700 | 1 | _aBapiro, Tashinga E | |
| 700 | 1 | _aLolkema, Martijn P | |
| 700 | 1 | _aJodrell, Duncan I | |
| 700 | 1 | _aTuveson, David A | |
| 773 | 0 |
_tCancer discovery _gvol. 2 _gno. 3 _gp. 260-269 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/2159-8290.CD-11-0242 _zAvailable from publisher's website |
| 999 |
_c21781387 _d21781387 |
||